Trials / Conditions / Uncomplicated Falciparum Malaria

Uncomplicated Falciparum Malaria

9 registered clinical trials studyying Uncomplicated Falciparum Malaria.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Pharmacokinetics and Pharmacodynamics of the Gametocytocidal and Post-treatment Chemoprotective Effects of Ant NCT04009343	Johns Hopkins Bloomberg School of Public Health	Phase 2 / Phase 3
Completed	Efficacy and Safety of ASAQ and PD for the Treatment of Uncomplicated Falciparum Malaria in Mainland Tanzania NCT03431714	National Institute for Medical Research, Tanzania	Phase 4
Withdrawn	Arterolane-PQP Versus DHA-PQP in Uncomplicated Falciparum Malaria in Eastern Myanmar NCT02461186	University of Oxford	Phase 2 / Phase 3
Completed	Efficacy and Safety of Artesunate-amodiaquine-methylene for Malaria Treatment in Children NCT01407887	Heidelberg University	Phase 2
Withdrawn	Artemisone for the Treatment of Uncomplicated Falciparum Malaria in Western Cambodia NCT00936767	University of Oxford	Phase 2 / Phase 3
Unknown	Effectiveness of Artemisinin Combination Regimens in Falciparum Malaria NCT00902811	Medecins Sans Frontieres, Netherlands	Phase 4
Completed	A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan NCT00682578	University of Oxford	Phase 3
Completed	Azithromycin Combination Therapy for the Treatment of Uncomplicated Falciparum Malaria in Bangladesh NCT00356005	Medical University of Vienna	Phase 2
Completed	Trial of Artesunate Combination Therapy in Pakistan NCT00959517	London School of Hygiene and Tropical Medicine	Phase 2